2 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Nephropathic Cystinosis: new trials by email Literature Review of Nephropathic Cystinosis trials Research Report on Nephropathic Cystinosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of TTI-0102 in Cystinosis TTI-0102 (cysteamine-pantetheine disulfide) - Nephropathic Cystinosis, Cystinosis | Phase 2 | Not yet recruiting | Thiogenesis Therapeutics, Inc. | 6 | 2026-10-01 | 2026-09-23 |
| DFT383 in Pediatric Participants With Nephropathic Cystinosis DFT383 - Nephropathic Cystinosis | Phase 1 / Phase 2 | Recruiting | Novartis Pharmaceuticals | 30 | 2025-06-02 | 2026-10-16 |
| Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients Cysteamine Bitartrate - Nephropathic Cystinosis | Unknown | Chiesi SA/NV | 31 | 2020-07-31 | 2021-11-29 | |
| CYSTEA-BONE Clinical Study Blood sampling - Nephropathic Cystinosis | Completed | Hospices Civils de Lyon | 42 | 2019-04-05 | 2026-10-22 | |
| Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™ Cysteamine bitartrate - Cystinosis, Nephropathic Cystinosis | Not applicable | Completed | University of California, San Diego | 8 | 2011-09-01 | 2013-10-09 |
| Cure Cystinosis International Registry Cystinosis, Nephropathic Cystinosis | Unknown | Cystinosis Research Foundation | 750 | 2010-08-01 | 2014-03-12 | |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Rare Disorders, Undiagnosed Disorders | Recruiting | Sanford Health | 20000 | 2010-07-01 | 2026-10-28 |
Cystinosis (7) · Fanconi Syndrome (2) · Lysosomal Storage Diseases (2) · Rare Diseases (2) · 3-Methylglutaconic Aciduria, Type V (1) · Achalasia Addisonianism Alacrimia syndrome (1) · Acrodysostosis (1) · Activated PI3K-delta Syndrome (1) · Addison Disease (1) · Alagille Syndrome (1) · Alstrom Syndrome (1) · Amnesia, Transient Global (1) · Aniridia (1) · Aniridia and Absent Patella (1) · Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Genetic Diseases, Inborn (7) · Nutritional and Metabolic Diseases (7) · Metabolic Diseases (6) · Metabolism, Inborn Errors (6) · Lysosomal Storage Diseases (5) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Renal Tubular Transport, Inborn Errors (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Disease Attributes (2) · Pathologic Processes (2)
Cysteamine (2) · Blood Specimen Collection (1) · cysteamine-pantetheine disulfide (1)
Chiesi SA/NV (1) · Cystinosis Research Foundation (1) · Hospices Civils de Lyon (1) · Novartis Pharmaceuticals (1) · Sanford Health (1) · Thiogenesis Therapeutics, Inc. (1) · University of California, San Diego (1)
United States (4) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Turkey (Türkiye) (1)
Jerry A Schneider, M.D. (1) · Laurence A Greenbaum, MD, PhD, FAAP (1) · Patrice P Rioux, MD, PhD (1) · Ranjan Dohil, M.D. (1)